Director

BoardBookit Rebrands to Govenda, Expands Company Vision and Platform

Wednesday, April 7, 2021 - 1:59pm

The product evolution, from a board portal to a board relationship and compliance management platform, is the driving force behind the rebranding.

Key Points: 
  • The product evolution, from a board portal to a board relationship and compliance management platform, is the driving force behind the rebranding.
  • The Govenda board relationship management platform addresses this need and optimizes board performance through seamless and secure document exchange, reporting, and communications.
  • Customers use the platform to ensure board directors are informed, engaged, communicating, and driving company performance and strong corporate governance.
  • Govenda, by BoardBookit, is a board of directors relationship and compliance management platform that offers a suite of products to optimize board performance.

HKIoD Releases Revised Guide for INEDs

Wednesday, April 7, 2021 - 1:58am

To provide up-to-date practice guidance, The Hong Kong Institute of Directors ("HKIoD") releases a complete revision of one of its flagship publications, Guide for Independent Non-Executive Directors ("the Guide").

Key Points: 
  • To provide up-to-date practice guidance, The Hong Kong Institute of Directors ("HKIoD") releases a complete revision of one of its flagship publications, Guide for Independent Non-Executive Directors ("the Guide").
  • "While listed companies are mandated by Listing Rules to appoint INEDs to the board, non-listed companies may introduce diversity in perspectives on the board by appointing INEDs."
  • One important emphasis of the Guide is on corporate sustainability through ESG adoption and reporting led by the board, with INEDs serving as catalyst.
  • The HKIoD Guide for Independent Non-Executive Directors can be downloaded for free and nominations of candidates for Directors Of The Year Awards 2021 are welcomed.

Tryp Therapeutics Appoints Greg McKee as Chief Executive Officer

Thursday, April 1, 2021 - 12:00pm

San Diego, California--(Newsfile Corp. - April 1, 2021) - Tryp Therapeutics Inc. (CSE: TRYP) ("Tryp" or the "Company"), a pharmaceutical company focused on developing clinical-stage compounds for diseases with unmet medical needs, is pleased to announce that it has appointed Greg McKee as its Chief Executive Officer.

Key Points: 
  • San Diego, California--(Newsfile Corp. - April 1, 2021) - Tryp Therapeutics Inc. (CSE: TRYP) ("Tryp" or the "Company"), a pharmaceutical company focused on developing clinical-stage compounds for diseases with unmet medical needs, is pleased to announce that it has appointed Greg McKee as its Chief Executive Officer.
  • Mr. McKee will also continue in his responsibilities as Chairman of the Board of Directors of the Company.
  • He was previously appointed as Chairman of the Board of Directors of Tryp in February 2021.
  • We are fortunate to have him serve the company in this expanded capacity as Chief Executive Officer."

Arrival Announces Two New Members to Global Board of Directors

Monday, March 22, 2021 - 8:00am

Arrivals initial global Board of Directors is expected to include:

Key Points: 
  • Arrivals initial global Board of Directors is expected to include:
    Peter Cuneo, Chief Executive Officer and Chairman of the Board of Directors, CIIG
    F. Peter Cuneo has been Chief Executive Officer and Chairman of Board of Directors at CIIG Merger Corp. (NASDAQ: CIIC) since its inception in 2019.
  • At Arrival, he will serve as Non-Executive Chairman of the Board as well as a member of the Boards Audit Committee.
  • Arrival has now announced all of its nominees for global Board of Directors, including the final two members - Tawni Nazario-Cranz and Rex Tibbens.
  • Neither Arrival Group, Arrival nor CIIG gives any assurance that either Arrival Group, Arrival or CIIG will achieve its expectations.

Executive and Board Remuneration Report: A Study of Trends in Board Compensation and Pay Structure - ResearchAndMarkets.com

Monday, March 15, 2021 - 5:09pm

The "The 2020 Executive and Board Remuneration Report" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "The 2020 Executive and Board Remuneration Report" report has been added to ResearchAndMarkets.com's offering.
  • The Executive and Board Remuneration Report offers a detailed analysis of Board level compensation.
  • The report covers 5 years from FY16 to FY20 and covers both executive and non-executive Directors including Chairmen, CEOs, CFOs, Company Secretaries, Executive Directors, Non-Executive Directors (NEDs) and Non-Executive Chairmen.
  • The analysis also includes many non-compensation parameters such as Board size, independence, governance, gender diversity, and so on.

HF Foods Group Announces the Resignation of Mr. Zhou Min Ni as Co-Chief Executive Officer and Chairman of the Board of Directors and the Appointment of Russell T. Libby as Chairman of the Board of Directors

Thursday, February 25, 2021 - 1:00pm

The current Co-CEO, Mr. Peter Zhang, will become sole CEO and assume full executive responsibility of the Companys day-to-day operations with immediate effect.

Key Points: 
  • The current Co-CEO, Mr. Peter Zhang, will become sole CEO and assume full executive responsibility of the Companys day-to-day operations with immediate effect.
  • The board of directors has also unanimously appointed Mr. Russell T. Libby as the new chairman of the board of directors with immediate effect.
  • From 2007 to 2019, he held numerous leadership positions at Sysco Corporation and last served as Syscos executive vice president and corporate secretary.
  • Mr. Russell Libby, Chairman of the Board of Directors said: I am grateful for the trust of my fellow board members in appointing me to this leadership position.

Alex Tan appointed CEO of Hyva, Marco Mazzù appointed Chairman

Wednesday, February 24, 2021 - 10:31am

He succeeds Marco Mazz, who is appointed as Chairman of the Board.

Key Points: 
  • He succeeds Marco Mazz, who is appointed as Chairman of the Board.
  • Alex was appointed the Managing Director of Hyva China in 2004 and has since led the business with distinction, overseeing its meteoric growth from inception to market leadership.
  • He was appointed Head of Hyva Asia in 2011 and also assumed global responsibility for Hyva's waste management line of business in 2015.
  • The current CEO, Marco Mazz, will be moving into the role of Chairman.

Alex Tan appointed CEO of Hyva, Marco Mazzù appointed Chairman

Wednesday, February 24, 2021 - 10:27am

He succeeds Marco Mazz, who is appointed as Chairman of the Board.

Key Points: 
  • He succeeds Marco Mazz, who is appointed as Chairman of the Board.
  • Alex was appointed the Managing Director of Hyva China in 2004 and has since led the business with distinction, overseeing its meteoric growth from inception to market leadership.
  • He was appointed Head of Hyva Asia in 2011 and also assumed global responsibility for Hyva's waste management line of business in 2015.
  • The current CEO, Marco Mazz, will be moving into the role of Chairman.

Triterras Appoints Global Finance Veteran Adrian Kow Tuck Hoong to Board of Directors

Tuesday, February 9, 2021 - 1:00pm

SINGAPORE, Feb. 09, 2021 (GLOBE NEWSWIRE) -- Triterras Inc. (Nasdaq: TRIT, TRITW), a leading fintech company for trade and trade finance, has appointed Adrian Kow Tuck Hoong to its board of directors, effective January 29, 2021.

Key Points: 
  • SINGAPORE, Feb. 09, 2021 (GLOBE NEWSWIRE) -- Triterras Inc. (Nasdaq: TRIT, TRITW), a leading fintech company for trade and trade finance, has appointed Adrian Kow Tuck Hoong to its board of directors, effective January 29, 2021.
  • With these changes, the Triterras Board of Directors remains at seven total members, four of whom are independent.
  • Adrian brings to Triterras more than 30 years of experience and leadership in financial planning and reporting, strategic and corporate finance, and risk management.
  • On behalf of the entire Triterras organization, I would like to formally welcome Adrian to our Board of Directors, said Srinivas Koneru, Chairman and CEO of Triterras.

EQS-News: Relief Announces Resignation of Thomaz Burckhardt as Member of the Board of Directors

Tuesday, February 9, 2021 - 7:01am

Geneva, Switzerland, February 09, 2021 - RELIEF THERAPEUTICS Holding AG (SIX: RLF, OTCQB: RLFTF) ("Relief" or the "Company") announces the resignation, effective immediately, of Board of Directors member Thomaz Burckhardt.

Key Points: 
  • Geneva, Switzerland, February 09, 2021 - RELIEF THERAPEUTICS Holding AG (SIX: RLF, OTCQB: RLFTF) ("Relief" or the "Company") announces the resignation, effective immediately, of Board of Directors member Thomaz Burckhardt.
  • Mr. Burckhardt has resigned to focus his time and efforts on other professional duties and interests.
  • Raghuram (Ram) Selvaraju, Chairman of the Board of Relief, commented: "The Board of Directors and I would like to warmly thank Thomaz for his many contributions to the Company over the past years.
  • Relief will evaluate potential candidates to serve on the Board of Directors who have substantial life sciences/healthcare experience with respect to appointing a new independent director to fill the current vacancy.